Furthermore, HAPI analysis identified potentially novel oncogenes that hijack enhancers in trans, such as CRKL in the colorectal cancer cell line HT29 and FOXJ2 in the small cell lung cancer cell line NCIH2171 (Figs. 2D and S2A). The gene discussed is CRKL; the disease is small cell lung carcinoma.